PE20091782A1 - Derivados de sulfonamida sustituida - Google Patents
Derivados de sulfonamida sustituidaInfo
- Publication number
- PE20091782A1 PE20091782A1 PE2009000496A PE2009000496A PE20091782A1 PE 20091782 A1 PE20091782 A1 PE 20091782A1 PE 2009000496 A PE2009000496 A PE 2009000496A PE 2009000496 A PE2009000496 A PE 2009000496A PE 20091782 A1 PE20091782 A1 PE 20091782A1
- Authority
- PE
- Peru
- Prior art keywords
- piperidin
- pyridin
- aryl
- alkyl
- metoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE SULFONAMIDA DE FORMULA (I) DONDE m, o, p Y r SON CADA UNO DE 0 A 2; n ES 1 O 2; q ES DE 0 A 3; v Y w SON CADA UNO 0 O 1; An- ES ANION DE HALOGENURO; Q ES UN ENLACE SIMPLE, -O- O -CH2; R1 ES ARILO O HETEROARILO OPCIONALMENTE UNIDO MEDIANTE UN ALQUILENO(C1-C3); R2 ES H, ALQUILO(C1-C6), CICLOALQUILO(C3-C8), ENTRE OTROS; R3 ES H, ALQUILO(C1-C6), ARILO, ENTRE OTROS; R4 ES ARILO O HETEROARILO OPCIONALMENTE UNIDO MEDIANTE UN ALQUILENO(C1-C6); R5 Y R6 SON CADA UNO H, ALQUILO(C1-C6), CICLOALQUILO(C3-C8), ENTRE OTROS; R20 ES ALQUILO(C1-C6), CICLOPROPILO, ARILO, =O, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 4-((1-(4-METOXI-2,6-DIMETILFENILSULFONIL)PIPERIDIN-2-IL)-1-(4-(PIRIDIN-3-IL)-4-(2-PIRROLIDIN-1-IL)ETOXI)PIPERIDIN-1-IL)BUTAN-1-ONA, N-CICLOPROPILO-4-METOXI-2,6-DIMETIL-N-(2-(2-OXO-2-(4-(PIRIDIN-3-IL)-4-(2-(PIRROLIDIN-1-IL)ETOXI)PIPERIDIN-1-IL)ETOXI)ETIL)BENZOSULFONAMIDA, 4-METOXI-2,6-DIMETIL-N-(2-(2-OXO-2-(4-(PIRIDIN-3-IL)-4-(2-(PIRROLIDIN-1-IL)ETOXI)PIPERIDIN-1-IL)ETOXI)ETIL)-N-(PIRIDIN-3-ILMETIL)BENZOSULFONAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR DE BRADIQUININA 1 (B1R) SIENDO UTILES EN EL TRATAMIENTO DE DOLORES AGUDOS, MIGRANA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08006957 | 2008-04-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20091782A1 true PE20091782A1 (es) | 2009-11-15 |
Family
ID=39967424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2009000496A PE20091782A1 (es) | 2008-04-08 | 2009-04-08 | Derivados de sulfonamida sustituida |
Country Status (14)
Country | Link |
---|---|
US (1) | US8318769B2 (es) |
EP (1) | EP2262792A1 (es) |
JP (1) | JP2011517459A (es) |
CN (1) | CN102056919B (es) |
AR (1) | AR071363A1 (es) |
AU (1) | AU2009235634B8 (es) |
CA (1) | CA2720793A1 (es) |
CL (1) | CL2009000851A1 (es) |
IL (1) | IL208519A0 (es) |
MX (1) | MX2010011095A (es) |
PE (1) | PE20091782A1 (es) |
RU (1) | RU2503674C2 (es) |
TW (1) | TW200948801A (es) |
WO (1) | WO2009124733A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2066659T1 (sl) * | 2006-09-29 | 2013-10-30 | Grunenthal Gmbh | Substituirani sulfonamidni derivati |
US8404741B2 (en) * | 2010-02-19 | 2013-03-26 | Bristol-Myers Squibb Company | Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase |
HUP1000598A2 (en) | 2010-11-05 | 2012-09-28 | Richter Gedeon Nyrt | Indole derivatives |
JP2014159375A (ja) * | 2011-06-15 | 2014-09-04 | Takeda Chem Ind Ltd | アゼパン化合物 |
CN107266378B (zh) * | 2016-04-06 | 2020-08-21 | 南开大学 | 含有磺酰基结构三嗪酮衍生物及其制备方法和在杀虫、杀菌方面的应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2743562B1 (fr) * | 1996-01-11 | 1998-04-03 | Sanofi Sa | Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant |
WO1998052937A2 (en) * | 1997-05-22 | 1998-11-26 | G.D. Searle And Co. | 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase |
FR2822827B1 (fr) * | 2001-03-28 | 2003-05-16 | Sanofi Synthelabo | Nouveaux derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant |
JP4593559B2 (ja) | 2003-03-25 | 2010-12-08 | ラボラトワール フルニエ エス・アー | ベンゼンスルホンアミド誘導体、その製造方法、及び、痛みを治療するためのその使用 |
US7425631B2 (en) * | 2003-04-10 | 2008-09-16 | Amgen Inc. | Compounds and methods of use |
MXPA05010883A (es) * | 2003-04-10 | 2006-01-23 | Amgen Inc | Derivados de amina ciclica y su uso en el tratamiento de trastornos inflamatorios relacionados mediados por bradiquinina. |
WO2007140383A2 (en) | 2006-05-30 | 2007-12-06 | Neurogen Corporation | Spirocyclic sulfonamides and related compounds |
DE102006039003A1 (de) * | 2006-08-19 | 2008-02-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Verbindungen |
WO2008024692A1 (en) | 2006-08-23 | 2008-02-28 | Neurogen Corporation | N-oxide aryl sulfones and sulfoxides |
SI2066659T1 (sl) * | 2006-09-29 | 2013-10-30 | Grunenthal Gmbh | Substituirani sulfonamidni derivati |
WO2008046573A1 (de) * | 2006-10-16 | 2008-04-24 | Grünenthal GmbH | Substituierte sulfonamid-derivate als bradykinin 1 rezeptor modulatoren |
DE102007020493A1 (de) * | 2007-04-30 | 2008-11-06 | Grünenthal GmbH | Substituierte Amid-Derivate |
DE102007020492A1 (de) * | 2007-04-30 | 2008-11-06 | Grünenthal GmbH | Substituierte Sulfonamid-Derivate |
TW200940528A (en) * | 2008-03-05 | 2009-10-01 | Gruenenthal Gmbh | Substituted sulfonamide derivatives |
TW200940523A (en) * | 2008-03-17 | 2009-10-01 | Gruenenthal Gmbh | Substituted sulfonamide derivatives |
PE20091731A1 (es) * | 2008-04-08 | 2009-11-11 | Gruenenthal Chemie | Derivados de sulfonamida sustituida |
DK2385938T3 (en) * | 2009-01-12 | 2015-04-27 | Pfizer Ltd | Sulfonamidderivater |
-
2009
- 2009-04-08 PE PE2009000496A patent/PE20091782A1/es not_active Application Discontinuation
- 2009-04-08 US US12/420,488 patent/US8318769B2/en not_active Expired - Fee Related
- 2009-04-08 CN CN200980121445.2A patent/CN102056919B/zh not_active Expired - Fee Related
- 2009-04-08 CA CA2720793A patent/CA2720793A1/en not_active Abandoned
- 2009-04-08 JP JP2011503376A patent/JP2011517459A/ja active Pending
- 2009-04-08 MX MX2010011095A patent/MX2010011095A/es active IP Right Grant
- 2009-04-08 AR ARP090101258A patent/AR071363A1/es not_active Application Discontinuation
- 2009-04-08 EP EP09730791A patent/EP2262792A1/de not_active Withdrawn
- 2009-04-08 WO PCT/EP2009/002578 patent/WO2009124733A1/de active Application Filing
- 2009-04-08 RU RU2010145013/04A patent/RU2503674C2/ru not_active IP Right Cessation
- 2009-04-08 CL CL2009000851A patent/CL2009000851A1/es unknown
- 2009-04-08 TW TW098111605A patent/TW200948801A/zh unknown
- 2009-04-08 AU AU2009235634A patent/AU2009235634B8/en not_active Ceased
-
2010
- 2010-10-06 IL IL208519A patent/IL208519A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2262792A1 (de) | 2010-12-22 |
US8318769B2 (en) | 2012-11-27 |
AU2009235634A8 (en) | 2013-05-23 |
WO2009124733A8 (de) | 2010-11-18 |
JP2011517459A (ja) | 2011-06-09 |
AU2009235634B2 (en) | 2013-04-18 |
IL208519A0 (en) | 2010-12-30 |
TW200948801A (en) | 2009-12-01 |
RU2503674C2 (ru) | 2014-01-10 |
CA2720793A1 (en) | 2009-10-15 |
AU2009235634A1 (en) | 2009-10-15 |
AR071363A1 (es) | 2010-06-16 |
CL2009000851A1 (es) | 2009-07-17 |
MX2010011095A (es) | 2010-11-05 |
AU2009235634B8 (en) | 2013-05-23 |
CN102056919B (zh) | 2014-03-12 |
US20090264400A1 (en) | 2009-10-22 |
RU2010145013A (ru) | 2012-05-20 |
WO2009124733A1 (de) | 2009-10-15 |
CN102056919A (zh) | 2011-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20210128A1 (es) | Inhibidores de la ectonucleotido pirofosfatasa-fosfodiesterasa 1 (enpp-1) y usos de los mismos | |
PE20120635A1 (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas | |
PE20090773A1 (es) | Derivados de morfolina pirimidina | |
PE20090816A1 (es) | Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3 | |
PE20142099A1 (es) | Derivados de sulfonamida | |
PE20090237A1 (es) | Derivados de sulfonamidas como inhibidores de los canales de sodio | |
PE20090621A1 (es) | Pirrolidina-aril-eteres como antagonistas de receptores de nk3 | |
EA200601785A1 (ru) | Соединения и способы лечения дислипидемии | |
PE20091842A1 (es) | Pirrolidinonas como activadores de glucoquinasa | |
PE20121050A1 (es) | Compuestos de n-(1-(4-(1h-pirazol-5-il)ftalazin-1-il)piperidin-4-il)-benzamida sustituidos como antagonistas de la trayectoria hedgehog | |
PE20070642A1 (es) | Compuestos derivados de pirazol como antagonistas del receptor de la progesterona | |
PE20091974A1 (es) | Derivados de indazoles sustituidos con fenil o piridinilo | |
PE20141375A1 (es) | Activadores de glucoquinasa | |
NO20073663L (no) | Tiazol-4-karboksamid-derivater som mGluR5 antagonister | |
NO20063470L (no) | Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister | |
PE20081665A1 (es) | Antagonistas del receptor de dopamina 2 de rapida disociacion | |
NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
PE20091039A1 (es) | IMIDAZO PIRAZINAS FUSIONADAS ARILO Y HETEROARILO [1,5-a] COMO INHIBIDORES DE LA FOSFODIESTERASA 10 | |
PE20071245A1 (es) | COMPUESTOS INDOL SULFONAMIDA COMO MODULADORES DEL RECEPTOR DE PROGESTERONA SELECTIVOS (SPRMs) | |
ATE521606T1 (de) | Quaternäre ammoniumsalze als m3-antagonisten | |
PE20090482A1 (es) | Derivados heterociclicos como antagonistas del receptor ccr2 | |
PE20090709A1 (es) | Compuestos heterociclico de 5 miembros | |
DE602005027230D1 (de) | Cgrp-rezeptorantagonisten | |
PE20140703A1 (es) | Derivados de heteroarilo como moduladores de nachr alfa 7 | |
PE20091090A1 (es) | Derivados de piperidina como agonistas de receptores muscarinicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |